3. GOOD HEALTH AND WELL-BEING

Quanterix Co. (NASDAQ:QTRX) Expected to Post Earnings of -$0.47 Per Share – MarketBeat

Quanterix Co. (NASDAQ:QTRX) Expected to Post Earnings of -$0.47 Per Share  MarketBeat

Wall Street analysts forecast that Quanterix Co. (NASDAQ:QTRX) will announce earnings of ($0.47) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Quanterix’s earnings, with the lowest EPS estimate coming in at ($0.67) and the highest estimate coming in at ($0.27). Quanterix reported earnings of ($0.31) per share in the same quarter last year, which would suggest a negative year over year growth rate of 51.6%. The business is expected to issue its next earnings results on Tuesday, March 1st.

According to Zacks, analysts expect that Quanterix will report full-year earnings of ($1.79) per share for the current year. For the next financial year, analysts anticipate that the firm will post earnings of ($1.79) per share, with EPS estimates ranging from ($2.55) to ($1.03). Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Quanterix.

Quanterix (NASDAQ:QTRX) last posted its quarterly earnings results on Thursday, November 4th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by ($0.13). Quanterix had a negative net margin of 44.63% and a negative return on equity of 11.88%. During the same quarter in the previous year, the business earned $0.07 EPS.

QTRX has been the topic of a number of research analyst reports. Zacks Investment Research downgraded shares of Quanterix from a “hold” rating to a “sell” rating in a research report on Wednesday, November 10th. Canaccord Genuity decreased their price target on shares of Quanterix from $90.00 to $75.00 and set a “buy” rating for the company in a research note on Thursday, August 5th.

(Ad)

Geologists predict that Nevada could hold 25% of the world’s lithium supply. And with lithium quickly becoming the most valuable (and important) metal on the planet, Nevada could quickly become one of the richest states in the USA…

Quanterix stock traded down $0.43 during trading hours on Wednesday, reaching $43.18. The stock had a trading volume of 18,344 shares, compared to its average volume of 339,203. The company has a fifty day simple moving average of $50.15 and a 200-day simple moving average of $52.49. Quanterix has a 52 week low of $40.05 and a 52 week high of $92.57. The stock has a market cap of $1.58 billion, a PE ratio of -31.75 and a beta of 1.45.

In other news, SVP David C. Duffy sold 1,667 shares of the firm’s stock in a transaction on Friday, November 19th. The stock was sold at an average price of $45.54, for a total value of $75,915.18. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO E Kevin Hrusovsky sold 5,000 shares of the stock in a transaction dated Wednesday, November 10th. The shares were sold at an average price of $55.18, for a total value of $275,900.00. The disclosure for this sale can be found here. In the last three months, insiders sold 32,844 shares of company stock valued at $1,731,644. Corporate insiders own 15.40% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the business. Eaton Vance Management bought a new position in shares of Quanterix in the first quarter worth about $25,000. FORA Capital LLC boosted its stake in Quanterix by 326.5% in the 2nd quarter. FORA Capital LLC now owns 1,224 shares of the company’s stock worth $72,000 after purchasing an additional 937 shares during the period. US Bancorp DE grew its holdings in Quanterix by 103.1% during the 2nd quarter. US Bancorp DE now owns 1,489 shares of the company’s stock valued at $87,000 after buying an additional 756 shares in the last quarter. Cutler Group LP bought a new stake in shares of Quanterix during the second quarter valued at approximately $87,000. Finally, Great West Life Assurance Co. Can lifted its holdings in shares of Quanterix by 68.9% in the first quarter. Great West Life Assurance Co. Can now owns 1,583 shares of the company’s stock worth $92,000 after buying an additional 646 shares in the last quarter. Institutional investors and hedge funds own 82.13% of the company’s stock.

About Quanterix

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development.

Recommended Story: What does a bar chart mean for investors?

Get a free copy of the Zacks research report on Quanterix (QTRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Quanterix (NASDAQ:QTRX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to

Should you invest $1,000 in Quanterix right now?

Before you consider Quanterix, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Quanterix wasn’t on the list.

While Quanterix currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Source: marketbeat.com

Leave a Comment